4 Min Read
GENEVA (Reuters) - Health officials around the world gave their backing to the AstraZeneca vaccine against COVID-19, after a study showing it had little effect against mild disease caused by the variant now spreading quickly in South Africa rang global alarm.
The prospect that new virus variants could evolve the ability to elude vaccines is one of the main risks hanging over the global strategy to emerge from the pandemic by rolling out vaccines this year.
South Africa, where a new variant now accounts for the vast bulk of cases, initially announced a pause in its rollout of a million doses of the AstraZeneca vaccine.
South Africa said on Sunday it would put on hold its use of the AstraZeneca shot after research showing it was only minimally effective in preventing mild-to-moderate illness against a variant in the country
<div class="at-above-post addthis tool" data-url="https://www.metro.us/global-health-officials-back/"></div>GENEVA (Reuters) – Health officials around the world gave their backing to the AstraZeneca vaccine against COVID-19, after a study showing it had little effect against mild disease caused by the variant now spreading quickly in South Africa rang global alarm. The prospect that new virus variants could evolve the ability to elude vaccines is […]<! AddThis Advanced Settings above via filter on get the excerpt ><! AddThis Advanced Settings below via filter on get the excerpt ><! AddThis Advanced Settings generic via filter on get the excerpt ><! AddThis Share Buttons above via filter on get the excerpt ><! AddThis Share Buttons below via filter on get the excerpt ><div class="at-below-post addthis tool" data-url="https://www.metro.us/global-health-officials-back/"></div&
Balloon Juice | Progress balloon-juice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from balloon-juice.com Daily Mail and Mail on Sunday newspapers.